Arthur Kuan

Insider Reports History

Location
Irvine, CA
Signature
/s/ Joshua F. Patterson, Attorney-in-Fact for Arthur Kuan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Arthur Kuan:

Company Role Class Num Shares Value Price $ Report Date Ownership
CG Oncology, Inc. Chief Executive Officer, Director Common Stock 136,151 $7,290,886 $53.55 04 Mar 2026 Direct
CG Oncology, Inc. Chief Executive Officer, Director Employee Stock Option (Right to Buy) 64,612 04 Mar 2026 Direct

Insider Reports Filed by Arthur Kuan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CGON CG Oncology, Inc. 04 Mar 2026 3 $0 4 Chief Executive Officer, Director 06 Mar 2026, 17:52
CGON CG Oncology, Inc. 15 Apr 2025 1 $0 4 Chief Executive Officer, Director 16 Apr 2025, 16:15
CGON CG Oncology, Inc. 04 Oct 2024 1 $0 4 Chief Executive Officer, Director 07 Oct 2024, 16:51
CGON CG Oncology, Inc. 24 Jan 2024 0 $0 3 Chief Executive Officer, Director 24 Jan 2024, 21:05